LinksterTX

Established in 2019

Our Team.

Iwan Zimmermann

Founder

Roger Dawson

Founder

Pascal Egloff

Founder

Linkster Therapeutics is a university spin-off
in Zurich, Switzerland.

Our expertise.

BIOLOGY & SYNTHESIS

The basics for drug discovery.
As pioneers for membrane protein research, we understand the biology, the production of tough targets & of any antibody drug format using our optimized workflows.

CANDIDATE IDENTIFICATION

You get what you select for.
Our immunization & display experience helps us determine what’s next, evolving our Sybody strategies to identify best, potent & conformation-selective antibodies.

CHARACTERIZE & SCREEN

Giving direction.
We are raising the bar & eliminate classical triaging by using our revolutionary Flycode screening technology to include pre-clinical development from the start.

PRECLINICAL DEVELOPMENT

In vivo drug discovery revolution.
Our team of Flycode champions optimizes the in vivo properties of clinical candidates with a throughput of hundreds of antibodies in just 1 animal.

PARTNER EXCELLENCE

Bridging innovation.
The world isn’t short on ideas & cutting-edge research that we understand, value & implement seamlessly in our processes or perform together with our strong partners.

THERAPEUTIC EFFICACY

The patient‘s benefit is our ambition.
We create key experiments & tangible results to determine the therapeutic performance of candidates, advocate for or against them & mitigate occurring risks.

more about us.

We are looking forward to working with you.